Methods And Compositions For Modifying Macrophage Polarization Into Pro-Inflammatory Cells To Treat Cancer

Patent No. EP4186927 (titled "Methods And Compositions For Modifying Macrophage Polarization Into Pro-Inflammatory Cells To Treat Cancer") was filed by OSE Immunotherapeutics on Oct 21, 2016. The application was issued on Apr 23, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BYONDISJan 22, 2026VAN GENT
STRAWMANJan 16, 2026POTTER CLARKSON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4186927

OSE IMMUNOTHERAPEUTICS
Application Number
EP23151596A
Filing Date
Oct 21, 2016
Status
Granted And Under Opposition
Mar 21, 2025
Publication Date
Apr 23, 2025